CLINICAL ARTICLE
Screw-Retained,
Screwmentable, or ASC:
How the Right Choice Is Made
and Who Makes It
The choice between a Ti-base crown, a screwmentable, and an ASC restoration is not a matter of preference. Each responds to a specific set of clinical conditions, and each carries a distinct mechanical and biological risk profile that the lab, not the prescription form, is responsible for managing.
What the Crown Bonds To, and How the Screw Exits
Among screw-retained and screwmentable implant restorations, whether single units or short-span bridges, the choice of components is commonly reduced to a single line on a prescription form. That reduction does not capture what actually differentiates the clinical outcomes. The more precise framework involves two intersecting decisions: what the ceramic restoration bonds to, and how the prosthetic screw exits.
The first decision is abutment type. It determines bonding surface area, component geometry, and how much control the lab has over the subgingival emergence corridor. A prefabricated Ti-base is a standardized titanium cylinder with a fixed diameter and height range. A custom CAD/CAM titanium abutment is milled to the specific case, with geometry designed around the patient's tissue height, implant position, and intended restoration anatomy. Both connect to the implant via a titanium-to-titanium interface. The differences between them are geometric and spatial, not material.
The second decision is screw channel design. A straight screw channel exits along the implant axis. An angulated screw channel, applicable to both Ti-base and custom abutment workflows for single and multi-unit restorations, redirects that exit up to 25 degrees in any direction [1]. The clinical benefit is significant: a 2023 CBCT analysis confirmed that ASC converts approximately 75% of anteriorly placed implants that would otherwise require cemented restorations into fully retrievable screw-retained ones [1]. The documented tradeoff is that non-axial torque delivery reduces screw preload retention compared to straight channels [2].
Understanding these two axes before prescribing is what makes the restoration decision clinical rather than habitual.
The Case Determines the Instrument
No single component design serves every clinical scenario. The decision follows from a small set of case-specific variables that should be evaluated before a prescription is written.
When the implant axis is favorable and restorative space is adequate, a Ti-base bonded restoration is clinically appropriate. When surface preparation and cement selection are correctly executed in the lab, debonding rates are low and survival rates are high across the literature [3, 4].
When the case involves limited bonding surface, a complex delivery workflow, or posterior molar anatomy requiring careful design management, a custom abutment screwmentable offers greater geometric control and increased bonding surface area. Preparable abutments with greater height produce significantly higher debonding resistance values than standard Ti-bases under equivalent loading conditions [5].
When the implant axis would place the screw access in an esthetically or functionally unacceptable position, an angulated screw channel resolves that without converting the case to a cemented restoration. ASC restorations show comparable marginal bone levels and soft tissue outcomes to straight channel restorations in short and medium-term studies [6, 7]. The tradeoff is screw loosening risk, which increases with angulation and requires correct torque protocol at delivery [2].
The decision is not a preference. It is a clinical read of what the case requires.
What the Prescription Form Does Not Capture
The restoration type selected on a prescription form determines what gets fabricated. It does not determine whether that restoration performs predictably over five or ten years. The variables that determine long-term outcome are controlled in the lab, and most are invisible to the clinician at delivery.
Ti-base height is the most consequential geometric variable. A systematic review confirmed that Ti-bases under 3.5mm carry meaningfully higher debonding risk under functional loading and should be used with caution in posterior restorations [8]. Selecting the correct height for the available restorative space is a lab decision made before the component is ordered.
Surface preparation determines bond strength independently of cement type. A 2023 study found that untreated Ti-bases produced retention values nearly six times lower than air-abraded surfaces under equivalent conditions [5]. Sandblasting parameters, abrasive particle size, and cleaning protocol are controlled at the bench, not at the chair.
Cement selection, bonding sequence, and internal fit accuracy each contribute to longevity in ways that are not visible on delivery and not recoverable after the fact. A marginal gap that allows micro-movement under load, or a bonding surface inadequately prepared before cementation, are silent failure initiators that trace back entirely to lab protocol [9].
The clinician who prescribes correctly and sends a well-documented case has done their part. Everything after that point belongs to the lab.
Same Restoration. Different Outcome.
Two cases. Same implant system. Same restoration type prescribed. Both delivered on time. Both looking acceptable at seating.
The first case arrived with a complete digital record: CBCT, intraoral scan, restorative space measurement, implant position, and occlusal load profile. The lab selected an appropriate Ti-base height, verified the bonding protocol for the ceramic material, and returned the restoration with a note confirming component rationale. At the three-year recall, the restoration is stable with no radiographic bone loss and intact margins.
The second case arrived with a scan and a prescription form. A 3mm Ti-base was used because restorative space appeared limited on the scan. The ceramic was bonded without material-specific surface preparation because that information was not communicated. At the eighteen-month recall there is early crestal bone loss, a detectable margin gap, and micro-movement of the ceramic on the Ti-base.
The prescription was identical. The clinical placement was identical. What differed was whether the lab and clinician had shared enough information to make the right decisions together.
A predictable restoration is not the product of a good prescription form. It is the product of a clinical conversation that happens before fabrication begins.
A Good Outcome Requires Both Sides of This Partnership
The variables that most reliably predict long-term implant restoration success are not material selection or retention type. They are the quality of clinical information shared before fabrication and the quality of decisions made in response to it [10].
A clinician who provides complete case documentation gives the lab what it needs to make component decisions that serve the case rather than default to the simplest option.
A lab that reviews that information, selects components deliberately, communicates its rationale, and flags concerns before fabrication begins gives the clinician something a price list cannot convey: clinical accountability.
This standard benefits both sides equally. A clinician whose lab thinks this way spends less time managing complications. A lab that operates this way builds relationships where the first case becomes the second, and the second becomes a protocol.
The restoration type matters. The component selection matters. The bonding protocol matters. But none of those variables operate in isolation from the clinical partnership that puts them in the right hands.
The best implant restoration is not the product of the best prescription.
It is the product of the best conversation.
References
-
Kan JYK et al. Frequency of screw-retained angulated screw channel single crown following immediate implant placement and provisionalization in the esthetic zone. Clin Implant Dent Relat Res. 2023;25(3):456-464.
-
Chiam SY et al. Mechanical and biological complications of angled versus straight screw channel implant-supported prostheses: a systematic review and meta-analysis. J Prosthet Dent. 2024.
-
Gehrke P et al. Retrospective multicenter cohort study evaluating clinical outcomes of implant-supported zirconia single crowns cemented on titanium-base abutments: 7-year mean follow-up. Int J Oral Maxillofac Implants. 2025;40(2):207-217
-
Chantler C et al. Clinical performance of single implant prostheses restored using titanium base abutments: a systematic review and meta-analysis. Clin Oral Implants Res. 2023;34:1089-1103.
-
PKhalifa AA, Metwally NA, Khamis MM. Evaluation of debonding force of screw-retained lithium disilicate implant-supported crowns cemented to abutments of different designs and surface treatments. J Prosthet Dent. 2025;133(1):215-220.
-
Di Fiore A et al. The application of angulated screw-channels in metal-free implant-supported restorations: a retrospective survival analysis. J Funct Biomater. 2021;12(4):66.
-
Atieh MA et al. Angled screw channel-retained vs. cement-retained implant crowns in nonmolar sites: a systematic review and meta-analysis. J Esthet Restor Dent. 2025;37(7):1706-1720.
-
Retention of CAD-CAM implant-supported ceramic restorations luted to titanium bases: a systematic review of in vitro studies. Clin Cosmet Investig Dent. 2025.
-
Moreno ALM et al. Abutment on titanium-base hybrid implant: a literature review. Eur J Dent. 2023;17(2):261-269.
-
Strasding M et al. Material and abutment selection for CAD/CAM implant-supported fixed dental prostheses in partially edentulous patients: a narrative review. Clin Oral Implants Res. 2024;35(8):984-999.
About the author
Ilan Sapir, CDT
Founder of DTS Dental Technology Solutions. 16 years in digital implant dentistry, including leading treatment planning workflows for full-arch and esthetic zone cases at scale. DTS works exclusively with experienced implant clinicians and oral surgeons.